279 related articles for article (PubMed ID: 8649425)
1. A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer.
Roque MC; Smith PA; Blasquez VC
Mol Cell Biol; 1996 Jun; 16(6):3138-55. PubMed ID: 8649425
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors.
Pongubala JM; Atchison ML
Mol Cell Biol; 1991 Feb; 11(2):1040-7. PubMed ID: 1899281
[TBL] [Abstract][Full Text] [Related]
3. Activating transcription factor 1 and cyclic AMP response element modulator can modulate the activity of the immunoglobulin kappa 3' enhancer.
Pongubala JM; Atchison ML
J Biol Chem; 1995 Apr; 270(17):10304-13. PubMed ID: 7730336
[TBL] [Abstract][Full Text] [Related]
4. The Igκ gene enhancers, E3' and Ed, are essential for triggering transcription.
Zhou X; Xiang Y; Garrard WT
J Immunol; 2010 Dec; 185(12):7544-52. PubMed ID: 21076060
[TBL] [Abstract][Full Text] [Related]
5. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.
Park K; Atchison ML
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9804-8. PubMed ID: 1946405
[TBL] [Abstract][Full Text] [Related]
6. YY1 binds to the E3' enhancer and inhibits the expression of the immunoglobulin κ gene via epigenetic modifications.
Zhou X; Xian W; Zhang J; Zhu Y; Shao X; Han Y; Qi Y; Ding X; Wang X
Immunology; 2018 Dec; 155(4):491-498. PubMed ID: 30098214
[TBL] [Abstract][Full Text] [Related]
7. The Ig kappa 3'-enhancer triggers gene expression in early B lymphocytes but its activity is enhanced on B cell activation.
Meyer KB; Teh YM; Neuberger MS
Int Immunol; 1996 Oct; 8(10):1561-8. PubMed ID: 8921435
[TBL] [Abstract][Full Text] [Related]
8. The 3' enhancer region determines the B/T specificity and pro-B/pre-B specificity of immunoglobulin V kappa-J kappa joining.
Hiramatsu R; Akagi K; Matsuoka M; Sakumi K; Nakamura H; Kingsbury L; David C; Hardy RR; Yamamura K; Sakano H
Cell; 1995 Dec; 83(7):1113-23. PubMed ID: 8548799
[TBL] [Abstract][Full Text] [Related]
9. A new hypersensitive site, HS10, and the enhancers, E3' and Ed, differentially regulate Igκ gene expression.
Zhou X; Xiang Y; Ding X; Garrard WT
J Immunol; 2012 Mar; 188(6):2722-32. PubMed ID: 22323542
[TBL] [Abstract][Full Text] [Related]
10. The Ig kappa 3' enhancer is activated by gradients of chromatin accessibility and protein association.
McDevit DC; Perkins L; Atchison ML; Nikolajczyk BS
J Immunol; 2005 Mar; 174(5):2834-42. PubMed ID: 15728493
[TBL] [Abstract][Full Text] [Related]
11. Chromatin remodeling at the Ig loci prior to V(D)J recombination.
Maës J; O'Neill LP; Cavelier P; Turner BM; Rougeon F; Goodhardt M
J Immunol; 2001 Jul; 167(2):866-74. PubMed ID: 11441093
[TBL] [Abstract][Full Text] [Related]
12. PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.
Pongubala JM; Nagulapalli S; Klemsz MJ; McKercher SR; Maki RA; Atchison ML
Mol Cell Biol; 1992 Jan; 12(1):368-78. PubMed ID: 1729611
[TBL] [Abstract][Full Text] [Related]
13. Identification of an octamer-binding site in the mouse kappa light-chain immunoglobulin enhancer.
Currie RA; Roeder RG
Mol Cell Biol; 1989 Oct; 9(10):4239-47. PubMed ID: 2511430
[TBL] [Abstract][Full Text] [Related]
14. Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases.
Liu Z; Garrard WT
Mol Cell Biol; 2005 Apr; 25(8):3220-31. PubMed ID: 15798207
[TBL] [Abstract][Full Text] [Related]
15. In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: a model for kappa locus activation.
Shaffer AL; Peng A; Schlissel MS
Immunity; 1997 Feb; 6(2):131-43. PubMed ID: 9047235
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mouse and rabbit Ei kappa enhancers indicates that different elements within the enhancer may mediate activation of transcription and recombination.
Coquilleau I; Cavelier P; Rougeon F; Goodhardt M
J Immunol; 2000 Jan; 164(2):795-804. PubMed ID: 10623825
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the human immunoglobulin kappa gene 3' enhancer: functional importance of three motifs that demonstrate B-cell-specific in vivo footprints.
Judde JG; Max EE
Mol Cell Biol; 1992 Nov; 12(11):5206-16. PubMed ID: 1406692
[TBL] [Abstract][Full Text] [Related]
18. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
Hodawadekar S; Park K; Farrar MA; Atchison ML
J Immunol; 2012 Mar; 188(5):2276-84. PubMed ID: 22279106
[TBL] [Abstract][Full Text] [Related]
19. Dynamic chromatin remodeling in the vicinity of J chain gene for the regulation of two stage-specific genes during B cell differentiation.
Kang CJ; Oh U; Koshland ME
Mol Cells; 2000 Feb; 10(1):32-7. PubMed ID: 10774744
[TBL] [Abstract][Full Text] [Related]
20. Chromatin structural analyses of the mouse Igkappa gene locus reveal new hypersensitive sites specifying a transcriptional silencer and enhancer.
Liu ZM; George-Raizen JB; Li S; Meyers KC; Chang MY; Garrard WT
J Biol Chem; 2002 Sep; 277(36):32640-9. PubMed ID: 12080064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
